An analysis of risk factors for early complications after liver transplantation

Jie EnBo; Xuan FengHui; Sun XiaoDong; Sun DaWei; Lu: GuoYue

doi:10.3969/j.issn.1001-5256.2018.06.030

Issue 6

Jun. 2018

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2018 > 34(6): 1282-1288

PDF( 1573 KB)

An analysis of risk factors for early complications after liver transplantation

DOI: 10.3969/j.issn.1001-5256.2018.06.030

First Department of Hepatopancreatobiliary Surgery, The First Hospital of Jilin University

Received Date: 2017-12-25
Published Date: 2018-06-20

Abstract

Abstract

Objective To investigate the risk factors for early complications after liver transplantation and to improve the prognosis. Methods The clinical data of 147 patients who underwent orthotopic liver transplantation in the Hepatic Transplantation Center of The First Hospital of Jilin University from September 2011 to April 2017 were retrospectively analyzed. According to the presence or absence of early complications after surgery, these patients were divided into non-complication group (n = 11) and complication group (n = 136) . The possible factors associated with early complications after surgery were collected, including donor factors (age and whether the blood type of the donor matches that of the recipient) , recipient factors (sex, age, primary disease, Model for End-Stage Liver Disease [MELD]score, aspartate aminotransferase [AST], alanine aminotransferase[ALT], albumin [Alb], platelet [PLT], hemoglobin [Hb], fibrinogen, total bilirubin, creatinine, PLT/Alb ratio [PAR], and neutrophil/lymphocyte ratio [NLR]) , intraoperative factors (cold ischemia time, warm ischemia time, intraoperative blood loss, and duration of anhepatic phase) , and postoperative factors (AST and ALT immediately and 12, 24, 48, and 72 hours after operation) . The clinical data were analyzed to investigate the association between these factors and early complications.The t test was used for comparison of normally distributed continuous data; the Mann-Whitney U test was used for comparison of non-normally distributed continuous data. The chi-square test was used for comparison of categorical data. Backward logistic regression was used for multivariate analysis. Results MELD score (t =-3. 86, P = 0. 002) , Alb (t = 2. 19, P = 0. 049) , PLT (Z = 467. 00, P = 0. 039) , PAR (Z = 500. 00, P = 0. 068) , fibrinogen (t = 1. 80, P = 0. 096) , TBil (Z =-1. 98, P = 0. 047) , preoperative AST (Z = 417. 00, P =0. 015) , and preoperative ALT (Z = 501. 50, P = 0. 070) were associated with postoperative complications. PAR and preoperative AST were independent risk factors for early complications (odds ratio [OR]= 3. 84, 95% confidence interval [CI]: 1. 03-14. 34, P < 0. 05; OR =0. 25, 95% CI: 0. 07-0. 94, P < 0. 05) . The 147 patients were divided into high-PAR group (PAR ≥3 × 109/g; n = 55) and low-PAR group (PAR < 3 × 109/g; n = 92) ; PAR was associated with postoperative vascular and biliary complications (χ2= 2. 87, P = 0. 090;χ2= 3. 54, P = 0. 060) . The 147 patients were divided into normal preoperative AST group (AST < 40 U/L; n = 93) and abnormal preoperative AST group (AST ≥40 U/L; n = 54) ; preoperative AST level was associated with postoperative pleural effusion (χ2= 3. 03, P =0. 082) . Conclusion Fibrinogen, PLT, Alb, TBil, PAR, MELD score, and preoperative AST and ALT are associated with the development of early complications after liver transplantation, and PAR and preoperative AST are independent risk factors for early complications.To improve the prognosis and postoperative survival, these factors, particularly PAR, should be fully assessed for the liver transplantation recipient before operation, and specific interventions should be provided accordingly.
- liver transplantation,
- postoperative complications,
- risk factors

FullText(HTML)

References(31)

References

[1]SHI YH, TIAN MX, FAN J.Recommendations for EASL clinical practice guidelines:liver transplantation (2015) [J].J Clin Hepatol, 2016, 31 (3) :429-431. (in Chinese) 史颖弘, 田孟鑫, 樊嘉.《欧洲肝病学会肝移植临床实践指南 (2015年) 》推荐意见[J].临床肝胆病杂志, 2016, 31 (3) :429-431.

[2]AZEVEDO LD, STUCCHI RS, ATAíDE EC.Assessment of causes of early death after twenty years of liver transplantation.[J].Transplant Proc, 2013, 45 (3) :1116-1118.

[3]DAI CL, YIN YE, LI H, et al.Significance of various detection methods in diagnosis of cytomegalovirus infection[J].Chin J Lab Diag, 2010, 14 (12) :2058-2059. (in Chinese) 戴春来, 尹艳娥, 李恒, 等.各种检测方法在巨细胞病毒感染诊断中的意义[J].中国实验诊断学, 2010, 14 (12) :2058-2059.

[4]CHEN XB, XU MQ.Primary graft dysfunction after liver transplantation[J].Hepatobiliary Pancreat Dis Int, 2014, 13 (2) :125-137.

[5]European Association for the Study of the Liver.EASL clinical practice guidelines:Liver transplantation[J].J Hepatol, 2016, 64 (2) :433-485.

[6]KOCHHAR G, PARUNGAO JM, HANOUNEH IA, et al.Biliary complications following liver transplantation[J].World J Gastroenterol, 2013, 19 (19) :2841-2846.

[7] WANG JY, LIAO EY, HUANG CX, et al.Internal medicine[M].Beijing:People's Medical Publishing House, 2013:662. (in Chinese) 王吉耀, 廖二元, 黄从新, 等.内科学[M].北京:人民卫生出版社, 2013:662.

[8]ZHOU L, PAN LC, SHI XJ, et al.Research advances in multicenter study on the role of the Model for End-Stage Liver Disease evaluation system in the selection of liver transplantation recipients[J].Organ Transplant, 2017, 8 (2) :174-178. (in Chinese) 周林, 潘立超, 史宪杰, 等.MELD评价体系对肝移植受者选择的多中心临床研究进展[J].器官移植, 2017, 8 (2) :174-178.

[9]SABATE A, DALMAU A.Fibrinogen:a clinical update on liver transplantation[J].Transplant Proc, 2015, 47 (10) :2925-2928.

[10]PORTE RJ, BLAUW E, KNOT EA, et al.Role of the donor liver in the origin of platelet disorders and hyperfibrinolysis in liver transplantation[J].J Hepatol, 1994, 21 (4) :592-600.

[11]JALAN R, SCHNURR K, MOOKERJEE RP, et al.Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality[J].Hepatology, 2009, 50 (2) :555-564.

[12]SHIRAI Y, SHIBA H, HARUKI K, et al.Preoperative platelet-to-albumin ratio predicts prognosis of patients with pancreatic ductal adenocarcinoma after pancreatic resection[J].Anticancer Res, 2017, 37 (2) :787-793.

[13]POROWSKI D, WIRKOWSKA A, HRYNIEWIECKA E, et al.Liver failure impairs the intrahepatic elimination of interleukin-6, tumor necrosis factor-alpha, hepatocyte growth factor, and transforming growth factor-beta[J].Biomed Res Int, 2015, 2015:934065.

[14]ALEXANDRAKIS MG, PASSAM FH, MOSCHANDREA IA, et al.Levels of serum cytokines and acute phase proteins in patients with essential and cancer-related thrombocytosis[J].Am J Clin Oncol, 2003, 26 (2) :135-140.

[15]GASTACA M.Biliary complications after orthotopic liver transplantation:A review of incidence and risk factors[J].Transplant Proc, 2012, 44 (6) :1545-1549.

[16]FREEMAN RB Jr, WIESNER RH, HARPER A, et al.The new liver allocation system:Moving toward evidence-based transplantation policy[J].Liver Transpl, 2002, 8 (9) :851-858.

[17] WANG XM, PENG CH, YAN JQ, et al.Relationship between Meld score and the perioperative complications and mortality after orthtopic liver transplantation[J].Chin J Organ Transplant, 2007, 28 (2) :105-107. (in Chinese) 王小明, 彭承宏, 严佶祺, 等.Meld评分与肝移植围手术期并发症及死亡率的相关性[J].中华器官移植杂志, 2007, 28 (2) :105-107.

[18]CHEN W, YI YX, ZHANG HB, et al.Evaluation effect of three scoring systems in the prediction of short-term outcomes following liver transplantation.[J].Chin J Hepatobiliary Surg, 2014, 20 (8) :557-561. (in Chinese) 陈威, 易永祥, 张海斌, 等.三种评分系统预测肝移植短期预后的效果评价[J].中华肝胆外科杂志, 2014, 20 (8) :557-561.

[19]WIEDERKEHR JC, IGREJA MR, NOGARA MS, et al.Analysis of survival after primary liver transplantation:Multivariate analysis of 155 cases in a single center[J].Transplant Proc, 2010, 42 (2) :511-512.

[20]SCHLEGEL A, LINECKER M, KRON P, et al.Risk assessment in high-and low-meld liver transplantation[J].Am J Transplant, 2017, 17 (4) :1050-1063.

[21]HALLDORSON JB, RAYHILL S, BAKTHAVATSALAM R, et al.Serum alkaline phosphatase and bilirubin are early surrogate markers for ischemic cholangiopathy and graft failure in liver transplantation from donation after circulatory death[J].Transplant Proc, 2015, 47 (2) :465-468.

[22]PLEVAK DJ, SOUTHORN PA, NARR BJ, et al.Intensive-care unit experience in the Mayo liver transplantation program:The first100 cases[J].Mayo Clinic Proceedings, 1989, 64 (4) :433-445.

[23]SHAHEEN AA, MYERS RP.Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C related fibrosis a systematic review[J].Hepatology, 2007, 46 (3) :912.

[24]EI SERAFY MA, KASSEM AM, OMAR H, et al.APRI test and hyaluronic acid as non-invasive diagnostic tools for post HCV liver fibrosis:Systematic review and meta-analysis[J].Arab J Gastroenterol, 2017, 18 (2) :51-57.

[25]JAIN A, REYES J, KASHYAP R, et al.Long-term survival after liver transplantation in 4, 000 consecutive patients at a single center[J].Ann Surg, 2000, 232 (4) :490-500.

[26]DUFOUR DR, LOTT JA, NOLTE FS, et al.Diagnosis and monitoring of hepatic injury.II.Recommendations for use of laboratory tests in screening, diagnosis, and monitoring[J].Clin Chem, 2000, 46 (12) :2050-2068.

[27]BAHDE R, SPIEGEL HU.Hepatic ischaemia-reperfusion injury from bench to bedside[J].Br J Surg, 2010, 97 (10) :1461-1475.

[28]ARDITE E, RAMOS C, RIMOLA A, et al.Hepatocellular oxidative stress and initial graft injury in human liver transplantation[J].J Hepatol, 1999, 31 (5) :921-927.

[29]GIANNINI EG, TESTA R, SAVARINO V.Liver enzyme alteration:A guide for clinicians[J].CMAJ, 2005, 172 (3) :367-379.

[30]SEETO RK, FENN B, ROCKEY DC.Ischemic hepatitis:Clinical presentation and pathogenesis[J].Am J Med, 2000, 109 (2) :109-113.

[31]DETRY O, DEROOVER A, MEURISSE N, et al.Donor age as a risk factor in donation after circulatory death liver transplantation in a controlled withdrawal protocol progrankme[J].Br J Surg, 2014, 101 (7) :784-792.

Relative Articles

[1]	Xin SHI, Chongxiao LIANG, Bei ZHANG, Jiping WANG. Value of internal stratification analysis of abdominal wall muscles in predicting complications after orthotopic liver transplantation[J]. Journal of Clinical Hepatology, 2025, 41(2): 314-321. doi: 10.12449/JCH250218
[2]	Decai KONG, Xiaojing ZHANG, Yangguang YUN, Haoyu DUAN, Junfeng YE. Risk factors for biliary stricture and prognosis after orthotopic liver transplantation[J]. Journal of Clinical Hepatology, 2024, 40(11): 2253-2259. doi: 10.12449/JCH241119
[3]	Mingqiang ZHU, Dashuai YANG, Junpeng PEI, Xiangyun XIONG, Yang SU, Youming DING. Analysis of influencing factors on biliary complications after orthotopic liver transplantation[J]. Journal of Clinical Hepatology, 2023, 39(7): 1627-1632. doi: 10.3969/j.issn.1001-5256.2023.07.017
[4]	Xing DAI, Ben GAO, Xinxin ZHANG, Yanyan SUN, Wentao JIANG, Jiang LI. Establishment and validation of a risk prediction model for early-stage complications after liver transplantation[J]. Journal of Clinical Hepatology, 2022, 38(2): 402-408. doi: 10.3969/j.issn.1001-5256.2022.02.027
[5]	Bing GUO, Mingquan PANG, Xiaolei XU, Junwei HAN, Haijiu WANG. Establishment and evaluation of a nomogram for predicting post-hepatectomy complications in two types of hepatic echinococcosis[J]. Journal of Clinical Hepatology, 2021, 37(11): 2626-2631. doi: 10.3969/j.issn.1001-5256.2021.11.027
[6]	Bo HE, Xin WANG, Feng WANG, Yandong SUN, Qingguo XU, Ge GUAN, Yunjin ZANG. Influence of arterial variation and reconstruction of the donor hepatic artery in liver transplantation on early postoperative arterial complications[J]. Journal of Clinical Hepatology, 2021, 37(8): 1901-1904. doi: 10.3969/j.issn.1001-5256.2021.08.030
[7]	Perioperative Management Group, Chinese Society of Organ Transplantation, Chinese Medical Association. Expert consensus on perioperative vascular complications for liver transplantation(2021)[J]. Journal of Clinical Hepatology, 2021, 37(9): 2054-2057. doi: 10.3969/j.issn.1001-5256.2021.09.010
[8]	Yun ZHAO, Lijin ZHAO. Research advances in the risk factors for infection after liver transplantation[J]. Journal of Clinical Hepatology, 2021, 37(8): 1957-1962. doi: 10.3969/j.issn.1001-5256.2021.08.046
[9]	Zhang DaLi, Feng DanNi, Zhang LiJuan, Tang RuJia, He Xi, Zhou Xia, Gao YinJie, Liu ZhenWen, Liu HongLing. Risk factors for recurrence after liver transplantation in patients with hepatocellular carcinoma and their prognosis[J]. Journal of Clinical Hepatology, 2020, 36(9): 1985-1989. doi: 10.3969/j.issn.1001-5256.2020.09.015
[10]	Liu YiHe, Zheng Hong, Shen ZhongYang. Tasks and strategies for the prevention and treatment of middle-and long-term complications after liver transplantation[J]. Journal of Clinical Hepatology, 2019, 35(11): 2386-2390. doi: 10.3969/j.issn.1001-5256.2019.11.002
[11]	Zheng WeiPing, Shen ZhongYang. Risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma and related control strategies[J]. Journal of Clinical Hepatology, 2019, 35(11): 2391-2395. doi: 10.3969/j.issn.1001-5256.2019.11.003
[12]	Chen Long, Li Yue. The risk factors and prediction systems for posthepatectomy complications[J]. Journal of Clinical Hepatology, 2019, 35(1): 217-221. doi: 10.3969/j.issn.1001-5256.2019.01.048
[13]	Xu Hui, Li Bing. Research advances in endoscopic treatment of biliary complications after liver transplantation[J]. Journal of Clinical Hepatology, 2018, 34(10): 2245-2250. doi: 10.3969/j.issn.1001-5256.2018.10.041
[14]	Han HuanLi, Zhang MingMan, Guo ChunBao, Kang Quan, Li YingCun, Pu CongLun. An analysis of postoperative complications in children with biliary atresia after liver transplantation[J]. Journal of Clinical Hepatology, 2017, 33(2): 316-319. doi: 10.3969/j.issn.1001-5256.2017.02.024
[15]	Zhang YinTao, Meng JinYing, Guo ChunGuang, Wang Hua. Risk factors for biliary complications after common bile duct exploration combined with primary suture[J]. Journal of Clinical Hepatology, 2017, 33(2): 304-307. doi: 10.3969/j.issn.1001-5256.2017.02.021
[16]	Wang XinWei, Zhao ZongGang. Risk factors for infectious complications after hepatectomy in patients with intrahepatic bile duct stones[J]. Journal of Clinical Hepatology, 2017, 33(9): 1754-1757. doi: 10.3969/j.issn.1001-5256.2017.09.025
[17]	Wang MingYue, Lu ZhiYan. Imaging evaluation of complications after liver transplantation[J]. Journal of Clinical Hepatology, 2016, 32(12): 2295-2299. doi: 10.3969/j.issn.1001-5256.2016.12.013
[18]	Ding ShiHua, Wu DongHai, Guo HaiJian, Liu Jun. Risk factors for long-term complications after endoscopic sphincterotomy for benign biliary and pancreatic diseases[J]. Journal of Clinical Hepatology, 2016, 32(5): 918-920. doi: 10.3969/j.issn.1001-5256.2016.05.022
[19]	Xing GuoQuan, Yan TianQing, Jia ZhiShuo, Kang TieLi. Risk factors for pancreatic fistula after pancreaticoduodenectomy and its prevention and treatment measures [J]. Journal of Clinical Hepatology, 2015, 31(12): 2110-2113. doi: 10.3969/j.issn.1001-5256.2015.12.029
[20]	Lu: GuoYue. Risk factors for biliary complications after liver transplantation from donation after cardiac death[J]. Journal of Clinical Hepatology, 2015, 31(12): 2027-2030. doi: 10.3969/j.issn.1001-5256.2015.12.009

Supplements(0)

Cited By

Cited by

Periodical cited type(15)

1.	江方正，王芳，张双双，施旼艳，郑娴庆，王桂云，范杰梅，李百强，童智慧，李维勤. 肝移植患者术后血糖调控方案的构建及应用. 医学研究与战创伤救治. 2024(04): 375-380 .
2.	陈琳，施海虹. 肝内胆管结石行腹腔镜肝叶切除术后胸腔积液风险因素分析及处理对策. 全科医学临床与教育. 2023(08): 711-714 .
3.	巫殷梅，张胜锋，黄寨，秦文波，文张，黄晓春，张云利. 供体高钠血症对肝移植患者术后胃肠功能、肝功能以及远期预后的影响. 现代消化及介入诊疗. 2022(02): 215-219 .
4.	岑福兰，朱炯亮，林正豪. 肝移植术后B超评估容量早期应用负平衡对患者康复进程的影响. 系统医学. 2021(13): 27-29 .
5.	丁利民，李新长，罗文峰，杨小刚，黄小梅，徐志丹. 体外膜肺氧合技术对脑心双死亡器官捐献供肝的保护作用. 临床肝胆病杂志. 2020(01): 145-148 . 本站查看
6.	陈林，赵良智，蔡艳俊，齐月，李婉玉. 先天性肝纤维化致肝功能衰竭行肝移植术1例报告及文献复习. 吉林大学学报(医学版). 2020(01): 159-163+211 .
7.	喀斯木·艾海提，阿卜杜萨拉木·艾尼，吐尔干艾力·阿吉，邵英梅，张瑞青，塔来提·吐尔干，蒋铁民，冉博，阿卜杜艾尼·啊卜力孜，米尔阿迪力·艾尔肯，温浩. 离体肝切除和自体肝移植术治疗终末期肝多房棘球蚴病的住院医疗费用分析. 中国寄生虫学与寄生虫病杂志. 2020(01): 53-57 .
8.	高禄化，彭梅娟，聂青和，王媛媛. 肝移植术后人类微小病毒B19感染致骨髓抑制1例报告. 临床肝胆病杂志. 2020(05): 1127-1128 . 本站查看
9.	周利平，崔恒，盛俊，胡婕，夏雪峰. Neuman干预模式在肝移植术后高血糖患者中的应用效果. 中国医药导报. 2020(28): 155-158 .
10.	田波彦，鲁华鹏，张胶琼，丁泓帆，刘文媛，田敏，吕毅，杨勤玲. 远程医疗机器人在心脏死亡器官捐献肝移植术后随访中的应用. 器官移植. 2019(01): 79-83 .
11.	徐雨，丁佑铭，赵凯亮. 肝移植术后脾动脉盗血综合征的诊治方法与预防进展. 中国医药导报. 2019(12): 27-30 .
12.	谭晓宇，陈晓兰，林金铭，梁佩乔，刘宝棋，欧阳青，霍枫. 机械灌注技术引领器官捐献与移植模式的变革——器官ICU时代即将到来?. 器官移植. 2019(04): 453-458 .
13.	龚雪屹，朱晓峰，胡泽民，汪谦. 原发性肝细胞癌肝移植预后相关因素的单中心研究. 中华普通外科学文献(电子版). 2019(06): 455-458 .
14.	陶一峰，李瑞东，沈丛欢，马震宇，张晓飞，张全保，金嫣婷，王正昕. 不同吻合方法在肝移植胆道重建中应用研究. 临床军医杂志. 2018(11): 1334-1336+1339 .
15.	赵晓飞，林栋栋，李宁，臧运金，郭庆良，武聚山，孙力波. 8例肝移植术后急性移植物抗宿主病的诊治体会. 临床肝胆病杂志. 2018(11): 2392-2396 . 本站查看

Other cited types(1)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (1779) PDF downloads(520)

An analysis of risk factors for early complications after liver transplantation

DOI: 10.3969/j.issn.1001-5256.2018.06.030